Philip Morris International has received authorization to sell IQOS tobacco heating device in the United States
The document was issued by the Food and Drug Administration (FDA) following a two-year study. The FDA concluded that selling the device within the US market is relevant from the prospective of “protecting public health,” since this device “produces fewer toxins than regular cigarettes.” This is the first electric tobacco heating device that is allowed for sale in the United States. Commenting on the FDA announcement, André Calantzopoulos, Philip Morris International CEO, said that “The FDA’s decision to authorize IQOS in the U.S. is an important step forward for the approximately 40 million American men and women who smoke. Some will quit. Most won’t, and for them IQOS offers a smoke-free alternative to continued smoking. In just two years, 7.3 million people around the world have abandoned cigarettes and switched completely to IQOS. Today’s decision by FDA makes this opportunity available to American adult smokers. ” Since the launch of IQOS in Japan and Italy in 2014, the product was launched on more than 40 countries around the world, including most European countries, as well as neighboring Russia, Ukraine and Romania. In Moldova, IQOS was launched in July 2018. Commenting on the decision of the FDA, one of the most influential organizations in the world to control the quality of food and medicines, international media notes that this confirms the validity of statements by Philip Morris International about the reduced amount of toxins in the IQOS aerosol. In the opinion of the producers, as a substitute for smoking cigarettes, this is a crucial technology in achieving a smoke-free future. // 02.05.2019 - InfoMarket.